Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer

Immune checkpoint inhibitors (ICIs) have become a promising area of research for cancer treatment. In addition to the well-known ICIs targeting PD-1/PD-L1, HLA-G/ILT-2/-4 is relatively new immune checkpoint that has been evaluated in early clinical trials in patients with advanced solid tumors. In t...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiong-Yuan, Chen, Yu-Xin, Han, Qiu-Yue, Zhang, Jiang-Gang, Zhou, Wen-Jun, Zhang, Xia, Ye, Yao-Han, Yan, Wei-Hua, Lin, Aifen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155601/
https://www.ncbi.nlm.nih.gov/pubmed/34054869
http://dx.doi.org/10.3389/fimmu.2021.679090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155601/
https://www.ncbi.nlm.nih.gov/pubmed/34054869
http://dx.doi.org/10.3389/fimmu.2021.679090

Ejemplares similares